Profil
Ryan Fox has worked as a Chief Operating Officer at Asalyxa Bio, Inc. and currently holds the position of Chief Business Operations Officer at Orange Grove Bio LLC.
Postes actifs de Ryan Fox
| Sociétés | Poste | Début |
|---|---|---|
Asalyxa Bio, Inc.
 Asalyxa Bio, Inc. Pharmaceuticals: MajorHealth Technology Asalyxa Bio, Inc. is a drug development and platform technology company that focuses on developing novel therapeutics to treat major unmet medical needs caused by the dysregulation of immune signaling. The company is based in Southfield, MI. The company's platform technology enables the delivery of existing and novel drugs directly into over-reactive immune cells, with applications across a wide array of disease areas and conditions. The company was founded by Marc Appel, who has been the CEO since incorporation. | Directeur des opérations | - |
Orange Grove Bio LLC
 Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation. | Directeur des opérations | 01/04/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Asalyxa Bio, Inc.
Asalyxa Bio, Inc. Pharmaceuticals: MajorHealth Technology Asalyxa Bio, Inc. is a drug development and platform technology company that focuses on developing novel therapeutics to treat major unmet medical needs caused by the dysregulation of immune signaling. The company is based in Southfield, MI. The company's platform technology enables the delivery of existing and novel drugs directly into over-reactive immune cells, with applications across a wide array of disease areas and conditions. The company was founded by Marc Appel, who has been the CEO since incorporation. | Health Technology |
Orange Grove Bio LLC
Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation. | Finance |
